Christopher R Piszczatoski (Chris Piszczatoski)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Knee Osteoarthritis

Respiratory Syndrome Coronavirus

Replacement Therapy

Top Venues

The Annals of pharmacotherapy

Expert opinion on pharmacotherapy

University of Florida College of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Florida College of Pharmacy Jul 01 2019

United States

Post-Doctoral Fellow :: Pharmacotherapy and translational research

Publications

Christopher R Piszczatoski, Steven M Smith
Pharmacological considerations when treating hypertensive patients for osteoarthritis. Expert opinion on pharmacotherapy 23 (15) (2022)
Jason G Powell, Christopher R Piszczatoski
Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon. The Annals of pharmacotherapy 56 (9) (2022)
Jason G Powell, Christopher R Piszczatoski, Eric Rubido
Orladeyo (Berotralstat): A Novel Oral Therapy for the Prevention of Hereditary Angioedema. The Annals of pharmacotherapy (2021)
Christopher R Piszczatoski, Jason G Powell
Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19. The Annals of pharmacotherapy 54 (8) (2020)